Davis Polk advised the sales agents in the transaction. The transaction consists in a new SEC-registered at-the-market offering program by Denali Therapeutics Inc. under which Denali...
Denali Therapeutics’ $400 Million At-The-Market Offering
Credo Technology Group’s $200 Million Initial Public Offering
Davis Polk advised Credo Technology Group Holding Ltd on the IPO while S&C represented the underwriters. Credo announced its $200 million initial public offering of 20,000,000 ordinary...
Senti Biosciences’ Business Combination with Dynamics Special Purpose Corp.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
Marathon Digital Holdings’ $650 Million Convertible Senior Notes Offering
Davis Polk advised Marathon Digital, while Latham & Watkins represented the initial purchasers in the offering. Marathon Digital Holdings, Inc., one of the largest enterprise Bitcoin...
Revolution Medicines’ $250 Million Shares Offering
Davis Polk advised the sales agent, Cowen, in the offering. Revolution Medicines, Inc. announced it may issue and sell shares of its common stock for up...
SiTime’s $518 Million Shares Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. SiTime Corporation executed its offering of 2,300,000 shares of common stock,...
Cryoport’s $249 Million Stock Offering
Davis Polk advised the placement agents in the offering. Cryoport executed its direct offering of 3,072,038 shares of its common stock, for total gross proceeds of approximately $249.1...
Cryoport’s $403 Million Notes Offering
Davis Polk advised the initial purchasers in the offering. Latham & Watkins represented Cryoport in the offering. Cryoport, Inc. executed the offering of $402.5 million aggregate...
First Advantage’s $345 Million Shares Offering
Simpson Thacher represented First Advantage, while Davis Polk advised the representatives of the several underwriters in the offering. First Advantage announced the $345 million secondary offering of...
SVB Financial’s $2.25 Billion Offerings of Notes and Preferred Stock
Davis Polk advised the sole book-running manager and representative of the several underwriters for the offerings. SVB Financial Group executed the offerings of $650 million aggregate...
Maravai LifeSciences’ $1 Billion Secondary Offering
Davis Polk & Wardwell represented the underwriters in the offering Maravai LifeSciences Holdings, Inc. annunced the $1 billion secondary offering of 20,000,000 shares of Class A common...
Carvana’s $750 Million Notes Offering
Kirkland & Ellis advised Carvana, while Davis Polk advised the representative of the initial purchasers on the offering. Carvana Co. executed its debt offering of $750 million aggregate...